Table 3.
Patient Group | All Patients | IL-1 Genotype Positive | IL-1 Genotype Negative | ||||||
---|---|---|---|---|---|---|---|---|---|
All ages | Total No. | No. with CAD (%) | OR (95% CI) | Total No. | No. with CAD (%) | OR (95% CI) | Total No. | No. with CAD (%) | OR (95% CI) |
Quartile I | 125 | 59 (47) | 1.00 | 77 | 35 (46) | 1.00 | 48 | 24 (50) | 1.00 |
Quartile II | 125 | 62 (50) | 1.10 (0.67–1.81) | 73 | 36 (49) | 1.17 (0.62–2.22) | 52 | 26 (50) | 1.00 (0.46–2.19) |
Quartile III | 125 | 68 (54) | 1.34 (0.81–2.19) | 75 | 37 (49) | 1.17 (0.62–2.21) | 50 | 31 (62) | 1.63 (0.73–3.65) |
Quartile IV | 124 | 79 (64) | 1.96 (1.18–3.26) | 74 | 52 (70) | 2.84 (1.45–5.55) | 50 | 27 (54) | 1.17 (0.53–2.60) |
OR (95%CI) for trend | 1.25 (1.06–1.46) | 1.35 (1.10–1.66) | 1.10 (0.86–1.42) | ||||||
P for trend | 0.007 | 0.004 | 0.45 | ||||||
Age ≤60 yr | |||||||||
Quartile I | 60 | 19 (33) | 1.00 | 33 | 9 (27) | 1.00 | 27 | 12 (44) | 1.00 |
Quartile II | 52 | 17 (32) | 0.75 (0.34 – 1.67) | 32 | 8 (25) | 0.89 (0.29 – 2.69) | 20 | 7 (35) | 0.67 (0.20–2.22) |
Quartile III | 64 | 27 (45) | 1.64 (0.80 – 3.38) | 43 | 18 (42) | 1.92 (0.73 – 5.10) | 21 | 12 (57) | 1.67 (0.53–5.27) |
Quartile IV | 63 | 41 (60) | 2.82 (1.36 – 5.87) | 40 | 29 (73) | 7.03 (2.50 – 19.77) | 23 | 9 (39) | 0.80 (0.26–2.49) |
OR (95%CI) for trend | 1.48 (1.17–1.87) | 1.99 (1.43–2.78) | 1.01 (0.71–1.45) | ||||||
P for trend | 0.001 | <0.001 | 0.94 | ||||||
Age >60 yr | |||||||||
Quartile I | 65 | 40 (59) | 1.00 | 44 | 26 (59) | 1.00 | 21 | 12 (57) | 1.00 |
Quartile II | 73 | 47 (65) | 1.28 (0.65–2.55) | 41 | 28 (68) | 1.49 (0.61–3.64) | 32 | 19 (59) | 1.10 (0.36–3.35) |
Quartile III | 61 | 41 (62) | 1.17 (0.57–2.40) | 32 | 19 (59) | 1.01 (0.40–2.56) | 29 | 19 (66) | 1.43 (0.45–4.52) |
Quartile IV | 61 | 38 (67) | 1.46 (0.70–3.02) | 34 | 23 (68) | 1.45 (0.57–3.69) | 27 | 18 (67) | 1.50 (0.46–4.87) |
OR (95%CI) for trend | 1.11 (0.88–1.39) | 1.08 (0.80–1.45) | 1.16 (0.81–1.68) | ||||||
P for trend | 0.38 | 0.61 | 0.42 |